Abstract
Intervertebral disc (IVD) degeneration (IDD) is a prevalent musculoskeletal disorder. Nucleus pulposus cells (NPCs) play a significant role in the normal functioning of the IVD. Myricetin is an agent that exerts anti-inflammatory and antioxidant effects in various pathological conditions. Here, we investigated the ameliorative effects of myricetin on the IVD degeneration. NPCs were obtained from the IVD of rats, and were treated with myricetin (0, 5, 10, 15, 20 μM) for 24 h before 20 ng/mL IL-1β stimulation. RT-qPCR, western blotting, and ELISA were applied to evaluate the levels of inflammatory factors (iNOS, COX-2, TNF-α, IL-6, PGE2, and Nitrite) and extracellular matrix (ECM)-associated components (MMP13, ADAMTS-5, aggrecan, and collagen II) in NPCs. Activation status of related signaling pathways (NF-κB and Nrf2) was determined using western blotting and immunofluorescence staining. Experimental rat models of IDD were established using a needle puncture method. Myricetin (20 mg/kg) was administrated intraperitoneally, and the degeneration was evaluated using histopathological analysis. Myricetin treatment attenuated the IL-1β-induced production of inflammatory factors in NPCs. Downregulation of aggrecan and collagen II as well as upregulation of MMP-13 and ADAMTS-5 in NPCs caused by IL-1β was reversed by myricetin treatment. Mechanistically, myricetin blocked NF-κB signaling by activation of Nrf2 in IL-1β-stimulated NPCs. Moreover, inhibition of Nrf2 reversed the protective effects of myricetin in NPCs. The in vivo experiments showed that myricetin ameliorated the IDD progression in rats. The present work suggests that Nrf2 is involved in the pathogenesis of IDD and shows the protective effects as well as the underlying mechanism of myricetin on Nrf2 activation in NPCs.
Similar content being viewed by others
Data Availability
The data used to support the findings of this study are included within the article.
References
Bai X et al (2022) Cyanidin attenuates the apoptosis of rat nucleus pulposus cells and the degeneration of intervertebral disc via the JAK2/STAT3 signal pathway in vitro and in vivo. Pharm Biol 60(1):427–436
Chagas VT et al (2018) Protective effects of a polyphenol-rich extract from Syzygium cumini (L.) skeels leaf on oxidative stress-induced diabetic rats. Oxid Med Cell Longev 2018:5386079
Chen Y et al (2020) Mfn2 is involved in intervertebral disc degeneration through autophagy modulation. Osteoarthritis Cartilage 28(3):363–374
Chen M et al (2021) Upregulation Sestrin2 protects against hydrogen peroxide-induced oxidative damage bovine mammary epithelial cells via a Keap1-Nrf2/ARE pathway. J Cell Physiol 236(1):392–404
Cho BO et al (2016) Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-κB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages. Biosci Biotechnol Biochem 80(8):1520–1530
Devi KP et al (2015) Molecular mechanisms underlying anticancer effects of myricetin. Life Sci 142:19–25
Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117(14):3720–3732
Grzanna MW et al (2020) Avocado/soybean unsaponifiables, glucosamine and chondroitin sulfate combination inhibits proinflammatory COX-2 expression and prostaglandin E2 production in tendon-derived cells. J Med Food 23(2):139–146
Gu R et al (2019) Moracin attenuates LPS-induced inflammation in nucleus pulposus cells via Nrf2/HO-1 and NF-κB/TGF-β pathway. Biosci Rep. https://doi.org/10.1042/BSR20191673
Han B et al (2008) A simple disc degeneration model induced by percutaneous needle puncture in the rat tail. Spine (phila Pa 1976) 33(18):1925–1934
Hemanta D et al (2016) Etiology for degenerative disc disease. Chin Med Sci J 31(3):185–191
Jeong JH et al (2010) Regeneration of intervertebral discs in a rat disc degeneration model by implanted adipose-tissue-derived stromal cells. Acta Neurochir (wien) 152(10):1771–1777
Johnson ZI et al (2015) Disc in flames: roles of TNF-α and IL-1β in intervertebral disc degeneration. Eur Cell Mater 30:104–116 (discussion 116–117)
Kan X et al (2019) Myricetin relieves LPS-induced mastitis by inhibiting inflammatory response and repairing the blood-milk barrier. J Cell Physiol. https://doi.org/10.1002/jcp.28288
Kepler CK et al (2013) The molecular basis of intervertebral disc degeneration. Spine J 13(3):318–330
Khan NM, Ahmad I, Haqqi TM (2018) Nrf2/ARE pathway attenuates oxidative and apoptotic response in human osteoarthritis chondrocytes by activating ERK1/2/ELK1-P70S6K-P90RSK signaling axis. Free Radic Biol Med 116:159–171
Kos N, Gradisnik L, Velnar T (2019) A brief review of the degenerative intervertebral disc disease. Med Arch 73(6):421–424
Kumar A et al (2004) Nuclear factor-kappaB: its role in health and disease. J Mol Med (berl) 82(7):434–448
Latief N et al (2015) Effect of trimeric myricetin rhamnoside (TMR) in carrageenan-induced inflammation and caecal ligation and puncture-induced lung oxidative stress in mice. Phytother Res 29(11):1798–1805
Lawson LY, Harfe BD (2017) Developmental mechanisms of intervertebral disc and vertebral column formation. Wiley Interdiscip Rev Dev Biol 6(6):e283
Lee YS, Choi EM (2010) Myricetin inhibits IL-1beta-induced inflammatory mediators in SW982 human synovial sarcoma cells. Int Immunopharmacol 10(7):812–814
Li Z et al (2015) MicroRNA in intervertebral disc degeneration. Cell Prolif 48(3):278–283
Li J et al (2018) Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation. Free Radic Biol Med 124:541–549
Liao HH et al (2017) Myricetin possesses potential protective effects on diabetic cardiomyopathy through inhibiting IκBα/NFκB and enhancing Nrf2/HO-1. Oxid Med Cell Longev 2017:8370593
Luoma K et al (2000) Low back pain in relation to lumbar disc degeneration. Spine (phila Pa 1976) 25(4):487–492
Millward-Sadler SJ et al (2009) Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 11(3):R65
Nasto LA et al (2012) ISSLS prize winner: inhibition of NF-κB activity ameliorates age-associated disc degeneration in a mouse model of accelerated aging. Spine (phila Pa 1976) 37(21):1819–1825
Pan X et al (2019) Activation of Nrf2/HO-1 signal with Myricetin for attenuating ECM degradation in human chondrocytes and ameliorating the murine osteoarthritis. Int Immunopharmacol 75:105742
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45
Risbud MV, Shapiro IM (2014) Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol 10(1):44–56
Roberts S et al (2006) Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 88(Suppl 2):10–14
Roberts S et al (2016) Ageing in the musculoskeletal system. Acta Orthop 87(sup363):15–25
Shao Z et al (2021) Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis. Osteoarthritis Cartilage 29(3):413–422
Swank KR et al (2020) Metabolomic profiling in the characterization of degenerative bone and joint diseases. Metabolites 10(6):223
Taheri Y et al (2020) Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications. BMC Complement Med Ther 20(1):241
Tu J et al (2017) Simvastatin inhibits IL-1β-induced apoptosis and extracellular matrix degradation by suppressing the NF-kB and MAPK pathways in nucleus pulposus cells. Inflammation 40(3):725–734
Wang SZ et al (2014) Cell and molecular biology of intervertebral disc degeneration: current understanding and implications for potential therapeutic strategies. Cell Prolif 47(5):381–390
Wang H et al (2020) Acacetin alleviates inflammation and matrix degradation in nucleus pulposus cells and ameliorates intervertebral disc degeneration in vivo. Drug Des Devel Ther 14:4801–4813
Weber KT et al (2015) Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics. Curr Rev Musculoskelet Med 8(1):18–31
Wu S et al (2016) Myricetin ameliorates brain injury and neurological deficits via Nrf2 activation after experimental stroke in middle-aged rats. Food Funct 7(6):2624–2634
Xia SF et al (2016) Regressive effect of myricetin on hepatic steatosis in mice fed a high-fat diet. Nutrients 8(12):799
Yang W et al (2015) Interleukin-1β in intervertebral disk degeneration. Clin Chim Acta 450:262–272
Yang ZJ et al (2019) Myricetin attenuated diabetes-associated kidney injuries and dysfunction via regulating nuclear factor (erythroid derived 2)-like 2 and nuclear factor-κB signaling. Front Pharmacol 10:647
Yao J et al (2019) Reversing ROS-mediated neurotoxicity by chlorogenic acid involves its direct antioxidant activity and activation of Nrf2-ARE signaling pathway. BioFactors 45(4):616–626
Zhang CC et al (2013) Effects of IGF-1 on IL-1β-induced apoptosis in rabbit nucleus pulposus cells in vitro. Mol Med Rep 7(2):441–444
Zhang Q et al (2016) Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway. Food Funct 7(10):4332–4342
Zheng G et al (2019) TFEB protects nucleus pulposus cells against apoptosis and senescence via restoring autophagic flux. Osteoarthritis Cartilage 27(2):347–357
Zuo R et al (2019) Rapamycin induced autophagy inhibits inflammation-mediated endplate degeneration by enhancing Nrf2/Keap1 signaling of cartilage endplate stem cells. Stem Cells 37(6):828–840
Acknowledgements
Not applicable.
Funding
The work was supported by Effects of Anxiety and Depression on Rehabilitation in Patients with Lumbar Spinal Stenosis After Open Surgery and Its Mechanism (Approval Number: WJ2021F121) and Clinical Study on The Treatment of Abdominal Distension After Thoracolumbar Fractures with Jiawei Taohe Chengqi Combined with Umbilical Paste (Approval Number: ZY2021F016).
Author information
Authors and Affiliations
Contributions
TM conceived and designed the experiments, TM and JF carried out the experiments. TM and JF analyzed the data. TM and JF drafted the manuscript. All authors agreed to be accountable for all aspects of the work. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical Approval
All animal experiments were approved by the Ethics Committee of Wuhan Myhalic Biotechnology Co., Ltd (Approval Number: HLK-20211206173) and were performed following the NIH Guide for the Care and Use of Laboratory Animals.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mao, T., Fan, J. Myricetin Protects Against Rat Intervertebral Disc Degeneration Partly Through the Nrf2/HO-1/NF-κB Signaling Pathway. Biochem Genet 62, 950–967 (2024). https://doi.org/10.1007/s10528-023-10456-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-023-10456-z